ibs glp 1 is not just a sensitivity issue—it’s an inflammatory condition., For many patients, GLP-1 medications do more than support weight loss. They address one of the root drivers of IBS: inflammation in 🌿 Irritable Bowel Syndrome (IBS):

Although the hypoglycemic effects were similar among the three BMI groups, it was intriguing to find that the HbA1c reduction in the normal BMI patients tended to be greater than that in the obese patients

45 It also protects against oxidative stress and prevents glycosylation of proteins which may confer protection against respiratory disease syndrome and lung failure

Overall, higher genetic GLP1R gene expression was associated with a lower risk of kidney disease progression accounting for baseline patient characteristics [including] body mass index and the presence or absence of diabetes, the authors wrote

The FDA regulates supplements differently from foods and medicines